From: The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma
GTVCM (cm3)
GTVCMP (cm3)
Wilcoxon signed-rank test
Group
Mean ± SD
p value
T1 (n = 12)
9.8 ± 3.7
11.5 ± 5.5
0.329
T2 (n = 8)
21.9 ± 8.7
19.4 ± 4.9
0.591
All (n = 20)
12.9 ± 7.7
13.5 ± 6.5
0.232